Skip to main content

Table 3 Serious adverse events following HPV vaccination

From: Answering human papillomavirus vaccine concerns; a matter of science and time

Study % vaccine % control Relative risk (95% CI)
Future I 1.8 1.7 1.07 (0.71-1.60)
Future II 0.7 0.9 0.83 (0.56-1.24)
Harper 4.1 3.5 1.17 (0.64-2.14)
Koutsky 0.3 0.3 1.34 (0.30-5.96)
Munoz 0.2 0.4 0.43 (0.11-1.65)
Villa 0.7 0.7 1.01 (0.14-7.10)
PATRICIA 7.5 7.5 1.00 (0.91-1.11)
Total 1.00 (0.91-1.09)
  1. Adapted from [6, 38]. Original trial data from FUTURE I/II [12], Harper, Koutsky [39], Munoz [3, 40], Villa [41], and PATRICIA [7].
\